Trial · NCT00103857
Results by group54
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 54
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in HbA1c (Hemoglobin A1C) at Week 24 | Sitagliptin 100 mg q.d. | -0.66 | 95% Confidence Interval -0.83 to -0.50 | Percent | |
| Change From Baseline in HbA1c (Hemoglobin A1C) at Week 24 | Metformin 500 mg b.i.d. | -0.82 | 95% Confidence Interval -0.98 to -0.66 | Percent | |
| Change From Baseline in HbA1c (Hemoglobin A1C) at Week 24 | Metformin 1000 mg b.i.d. | -1.13 | 95% Confidence Interval -1.29 to -0.97 | Percent | |
| Change From Baseline in HbA1c (Hemoglobin A1C) at Week 24 | Sitagliptin 50 mg b.i.d. + Metformin 500 mg b.i.d. | -1.40 | 95% Confidence Interval -1.56 to -1.24 | Percent | |
| Change From Baseline in HbA1c (Hemoglobin A1C) at Week 24 | Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d. | -1.90 | 95% Confidence Interval -2.06 to -1.74 | Percent | |
| Change From Baseline in HbA1c (Hemoglobin A1C) at Week 24 | Placebo/Metformin 1000 mg b.i.d. | 0.17 | 95% Confidence Interval 0.00 to 0.33 | Percent | |
| Change From Baseline in FPG (Fasting Plasma Glucose) at Week 24 | Sitagliptin 100 mg q.d. | -17.5 | 95% Confidence Interval -24.1 to -10.8 | mg/dL | |
| Change From Baseline in FPG (Fasting Plasma Glucose) at Week 24 | Metformin 500 mg b.i.d. | -27.3 | 95% Confidence Interval -34.0 to -20.7 | mg/dL | |
| Change From Baseline in FPG (Fasting Plasma Glucose) at Week 24 | Metformin 1000 mg b.i.d. | -29.3 | 95% Confidence Interval -35.9 to -22.6 | mg/dL | |
| Change From Baseline in FPG (Fasting Plasma Glucose) at Week 24 | Sitagliptin 50 mg b.i.d. + Metformin 500 mg b.i.d. | -47.1 | 95% Confidence Interval -53.7 to -40.6 | mg/dL | |
| Change From Baseline in FPG (Fasting Plasma Glucose) at Week 24 | Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d. | -63.9 | 95% Confidence Interval -70.5 to -57.3 | mg/dL | |
| Change From Baseline in FPG (Fasting Plasma Glucose) at Week 24 | Placebo/Metformin 1000 mg b.i.d. | 5.8 | 95% Confidence Interval -1.0 to 12.7 | mg/dL | |
| Change From Baseline in 2-Hour PMG (Post-Meal Glucose) at Week 24 | Sitagliptin 100 mg q.d. | -51.9 | 95% Confidence Interval -62.3 to -41.5 | mg/dL | |
| Change From Baseline in 2-Hour PMG (Post-Meal Glucose) at Week 24 | Metformin 500 mg b.i.d. | -53.4 | 95% Confidence Interval -63.6 to -43.2 | mg/dL | |
| Change From Baseline in 2-Hour PMG (Post-Meal Glucose) at Week 24 | Metformin 1000 mg b.i.d. | -78.0 | 95% Confidence Interval -88.3 to -67.6 | mg/dL | |
| Change From Baseline in 2-Hour PMG (Post-Meal Glucose) at Week 24 | Sitagliptin 50 mg b.i.d. + Metformin 500 mg b.i.d. | -92.5 | 95% Confidence Interval -102.6 to -82.5 | mg/dL | |
| Change From Baseline in 2-Hour PMG (Post-Meal Glucose) at Week 24 | Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d. | -116.6 | 95% Confidence Interval -126.4 to -106.7 | mg/dL | |
| Change From Baseline in 2-Hour PMG (Post-Meal Glucose) at Week 24 | Placebo/Metformin 1000 mg b.i.d. | 0.3 | 95% Confidence Interval -10.4 to 11.0 | mg/dL | |
| Change From Baseline in HbA1c (Hemoglobin A1C) at Week 54 | Sitagliptin 100 mg q.d. | -0.82 | 95% Confidence Interval -1.00 to -0.63 | Percent | |
| Change From Baseline in HbA1c (Hemoglobin A1C) at Week 54 | Metformin 500 mg b.i.d. | -1.01 | 95% Confidence Interval -1.18 to -0.83 | Percent |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00103857/results